Skip to content
← Study library

NCT05700747 · REGISTRY CONDITION SEARCH

Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma

Found through the registry condition index, not selected as a treatment recommendation. This discovery collection was restricted to studies with posted results.

Phase
NA
Status at capture
COMPLETED
Registry last update
2025-12-16

The purpose of this study is to explore whether a structured program can help reduce the challenges of decreased physical functioning and quality of life for participants with multiple myeloma by providing a customized exercise program and fostering engagement in meaningful activities. The name of the study intervention involved in this study is: Health Through Activity (HTA) (six-session, rehabilitation exercise regimen)

Open the original ClinicalTrials.gov record → · Download preserved record

What did the study report?

Outcomes, safety and baseline populations are separate source sections. Quality-of-life measures appear under their original outcome titles.

Who could take part
eligibility Criteria
Inclusion Criteria: -≥18 years of age * Diagnosed with multiple myeloma currently receiving maintenance therapy, * Experiencing disability as indicated by an answer of "yes" to the question "Do health problems interfere with your ability to carry out your social or day to day activities?" Exclusion Criteria: * Bone pain that is either a) new onset or increased in the past month or b) uncontrolled i.e., in the patient's estimation the bone pain "greatly interferes with daily activities" * History of fracture in the past 12 months without fixation, or * Any injury or medical condition that would prohibit being able to safely perform exercise as indicated by the Physical Activity Readiness Questionnaire\[29\] (i.e., atrial fibrillation, chest pain or angina, uncontrolled high blood pressure or hypertension, loss of balance due to dizziness in the past 12 months, or loss of consciousness in the past 12 months). * We will also exclude individuals with moderate or worse cognitive impairment as indicated by a score of 3 or less on the Callahan six item cognitive screening tool.
healthy Volunteers
false
minimum Age
18 Years
sex
ALL
std Ages
  1. ADULT
  2. OLDER_ADULT
Treatment arms and interventions
arm Groups
  1. description
    Participants will undergo study procedures as outlined: * Complete a baseline survey regarding activity level and quality of life. * Attend 6 weekly study visits at the MGH Institute of Health Professions IMPACT Practice Center. * Attend final study visit and complete the Satisfaction survey and an individual, semi-structured interview with site staff to supply feedback about the program. * After six weeks, complete the Satisfaction survey again.
    intervention Names
    1. Behavioral: Health Through Activity
    label
    Health Through Activity (HTA) Intervention
    type
    EXPERIMENTAL
interventions
  1. arm Group Labels
    1. Health Through Activity (HTA) Intervention
    description
    Six, weekly, customized sessions with licensed physical and occupational therapists.
    name
    Health Through Activity
    type
    BEHAVIORAL
Study design
allocation
NA
intervention Model
SINGLE_GROUP
masking Info
masking
NONE
primary Purpose
HEALTH_SERVICES_RESEARCH
Enrollment
count
5
type
ACTUAL
Registered outcome plans (not posted results)
primary Outcomes
  1. description
    Number participants enrolled / Number screened positive \& eligible. A rate of at least 75% will indicate feasibility.
    measure
    Rate of Participant Enrollment
    time Frame
    At screening
  2. description
    Defined as the number of participants completing each of the three study assessments to number of participants enrolled. A completion rate of 85% will indicate feasibility.
    measure
    Assessment Completion Rate
    time Frame
    Up to 4 months
  3. description
    Number patients screened/ Number patients identified as potentially eligible. Screening rate of at least 75% will indicate feasibility
    measure
    Screening Rate
    time Frame
    Up to 4 months
  4. description
    Number patients screening positive \& eligible / Number screened. Eligibility rate is influenced by how many people in the clinical population are experiencing disability. Based on our pilot study, expected rate to be at least 35%.
    measure
    Eligibility Rate
    time Frame
    Up to 4 months
secondary Outcomes
  1. description
    Defined as at least 75% of participants complete all six sessions of Health Through Activity (HTA) and if the mean number of sessions is greater than or equal to 4.
    measure
    Intervention Completion Rate
    time Frame
    Up to 3 months
  2. description
    Assessed by the Satisfaction survey which is a 7-item survey that is rated on a 5-point Likert scale. Any item on the Satisfaction survey that generates a mean score of \< 4 will trigger consideration of modification to the HTA program.
    measure
    Participant Satisfaction
    time Frame
    Up to 4 months
Full study description
brief Summary
The purpose of this study is to explore whether a structured program can help reduce the challenges of decreased physical functioning and quality of life for participants with multiple myeloma by providing a customized exercise program and fostering engagement in meaningful activities. The name of the study intervention involved in this study is: Health Through Activity (HTA) (six-session, rehabilitation exercise regimen)
detailed Description
The goal of this single arm, pilot study of the Health Through Activity (HTA) rehabilitation intervention for people living with multiple myeloma is to determine if investigators can feasibly deliver the program out of the IMPACT Practice Center at the MGH Institute for Health Professions. \- The six-session 'Health Through Activity' program provides a customized exercise plan and encourages engagement in activities to reduce disability and improve quality of life. * Study procedures including screening for eligibility, in-clinic visits, questionnaires, and surveys. * Participation in this research study is expected to last up to 4 months. It is expected that up to 20 people will take part in this research study. An internal grant from the Massachusetts General Hospital Institute of Health Professions is providing equipment and staffing for this study.
Source references
Source notices and limitations
    Discovery and provenance
    1. release id
      ctgov-registry-1336d216cbd1bbff780dac70
      edge id
      nct-edge-e63b1562d540475028e0
      requested nct id
      NCT05700747
      primary nct id
      NCT05700747
      source kind
      ctgov_condition_query
      source record id
      Source null
      source file sha256
      2314ce01316b2d7044d298c6d25eda12e99cc5f44273bc75efed6cd5e03a8c14
      payload sha256
      438f1ee93e321f9914bc6cc5b3a06019da984ef9e3e44b230f7c0fba45db2194
      payload
      clinical indication matching status
      condition_index_match_asserted_by_registry_not_reviewed
      end exclusive
      true
      id
      nct-edge-e63b1562d540475028e0
      link basis
      returned_by_explicit_condition_and_posted_results_filter_query
      nct id
      NCT05700747
      occurrences
      1. context exact
        NCT05700747
        end
        11
        exact text
        NCT05700747
        start
        0
      offset unit
      unicode_code_points
      query cond
      Plasma Cell Neoplasms
      query disease state id
      ds-plasma-cell-neoplasms
      source file
      /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-plasma-cell-neoplasms-000.json
      source file sha256
      2314ce01316b2d7044d298c6d25eda12e99cc5f44273bc75efed6cd5e03a8c14
      source json pointer
      /studies/848/protocolSection/identificationModule/nctId
      source kind
      ctgov_condition_query
      source record id
      Source null
      source string basis
      parsed_JSON_string_unmodified
      source string sha256
      f424e3787464cc96885b522f45d36965b96fb63b6b632b4b90f4bf1d65dd48e1

    Preserved source evidence · Not medical advice